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Renal Mass Ablation in the Octogenarian and Nonagenarian Population 
Callum Hamilton, Amanda Smolock*, MD, Collette Shaw, MD, Conor McKee, MD 
 
Introduction: The gold standard for the management of T1a and T1b renal tumors is 
partial nephrectomy. This study aims to analyze the outcomes of renal mass thermal 
ablations as an alternative therapy in the octogenarian and nonagenarian patient 
population, specifically. 
Methods: Departmental database of all percutaneous renal ablations performed 
between February 2008 and August 2019 was reviewed. 34 tumors were ablated in 19 
males and 15 females with a mean age of 84.1 ± 3.1 years (range 80-92 years). Patient 
demographics, procedural and postprocedural data were evaluated. 
Results: Ten microwave and 24 cryoablations were performed, all ablations were 
performed under CT guidance for 27 T1a and 7 T1b renal tumors (1.4-5.9cm). The 
mean Charlson comorbidity index was 6.7.  Thirty-one ablations were performed as the 
primary management, 3 were performed for tumor recurrence following partial 
nephrectomy (2) or prior ablation (1). The average number of probes used in 
cryoablation was 3.3 compared to 2.7 probes used in microwave ablation. Overall 
complication rate in cases in the 31 cases in which there was sufficient follow up was 
23% and major complication rate was 13%, including two episodes of bleeding requiring 
red blood cell transfusion. Additionally there was one incidentally detected 
pseudoaneurysm in the ablation cavity of an asymptomatic patient which was 
subsequently embolized more than one year following the ablation. The mean pre 
procedure creatinine was 1.20 and mean creatinine at least 3 months post procedure 
was 1.23. Of the 25 patients with at least 3 months of CT or MR follow up, there was no 
local recurrence and median follow-up was 23.7 months (range 1.1-94.9 months). 
Concurrent biopsies were performed in 31 of the 34 cases. The pathology showed a 
majority of clear cell renal cell carcinoma (15), followed by oncocytic neoplasm (7), 
nondiagnostic specimen (4) and papillary renal cell carcinoma (3).  
Discussion: Thermal ablation of renal masses in the elderly population is an effective 
treatment option with a low recurrence rate. Complications are higher than previously 
reported in the literature which may be related the advanced age and comorbidities of 
these patients. 
